SUBPART A—General Provisions (§310.3 to §310.6)
- 310.3—Definitions and interpretations.
- 310.4—Biologics; products subject to license control.
- 310.6—Applicability of “new drug” or safety or effectiveness findings in drug efficacy study implementation notices and notices of opportunity for hearing to identical, related, a